Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 13, 2011

AbbVie Biotechnology Limited v. The Mathilda and Terence Kennedy Institute of Rheumatology Trust

Track this case

Case Number:

1:11-cv-02541

Court:

New York Southern

Nature of Suit:

Patent

Judge:

Paul A. Crotty

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 26, 2013

    AbbVie Gets Humira Patent Invalidated As Obvious

    AbbVie Inc. has won a ruling in New York federal court declaring invalid a patent for the anti-inflammatory drug Humira held by the Mathilda and Terence Kennedy Institute of Rheumatology Trust, meaning the drugmaker no longer will have to pay the trust licensing fees.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login